665 related articles for article (PubMed ID: 32917884)
21. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
Clausen TM; Sandoval DR; Spliid CB; Pihl J; Perrett HR; Painter CD; Narayanan A; Majowicz SA; Kwong EM; McVicar RN; Thacker BE; Glass CA; Yang Z; Torres JL; Golden GJ; Bartels PL; Porell RN; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser BM; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Chanda SK; Schmidt AG; Godula K; Leibel SL; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
Cell; 2020 Nov; 183(4):1043-1057.e15. PubMed ID: 32970989
[TBL] [Abstract][Full Text] [Related]
22. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
Damas J; Hughes GM; Keough KC; Painter CA; Persky NS; Corbo M; Hiller M; Koepfli KP; Pfenning AR; Zhao H; Genereux DP; Swofford R; Pollard KS; Ryder OA; Nweeia MT; Lindblad-Toh K; Teeling EC; Karlsson EK; Lewin HA
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22311-22322. PubMed ID: 32826334
[TBL] [Abstract][Full Text] [Related]
23. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
24. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
Fantini J; Chahinian H; Yahi N
Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
[TBL] [Abstract][Full Text] [Related]
26. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
Wan Y; Shang J; Graham R; Baric RS; Li F
J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
28. The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor.
Yang Y; Du Y; Kaltashov IA
Anal Chem; 2020 Aug; 92(16):10930-10934. PubMed ID: 32678978
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
Wrobel AG; Benton DJ; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Nat Struct Mol Biol; 2020 Aug; 27(8):763-767. PubMed ID: 32647346
[TBL] [Abstract][Full Text] [Related]
30. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
Luan J; Lu Y; Jin X; Zhang L
Biochem Biophys Res Commun; 2020 May; 526(1):165-169. PubMed ID: 32201080
[TBL] [Abstract][Full Text] [Related]
31. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
Letko M; Marzi A; Munster V
Nat Microbiol; 2020 Apr; 5(4):562-569. PubMed ID: 32094589
[TBL] [Abstract][Full Text] [Related]
32. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
Choudhary S; Silakari O
Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
34. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
Chan KK; Dorosky D; Sharma P; Abbasi SA; Dye JM; Kranz DM; Herbert AS; Procko E
Science; 2020 Sep; 369(6508):1261-1265. PubMed ID: 32753553
[TBL] [Abstract][Full Text] [Related]
35. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
Basu A; Sarkar A; Maulik U
Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 challenging cell biology.
Bullerdiek J
Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
[No Abstract] [Full Text] [Related]
38. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
[TBL] [Abstract][Full Text] [Related]
39. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
40. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
Chen L; Li X; Chen M; Feng Y; Xiong C
Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
